Clinical trial
Effectiveness and Safety of Daktacort Feminine Care Cream in the Treatment of Vulvar Candidiasis
NCT01769339 is registered in ClinicalTrials.gov with Janssen Pharmaceutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Daktacort Feminine Care Cream in the Treatment of Vulvar Candidiasis
- Lead sponsor
- Janssen Pharmaceutica
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- June 30, 2009
- Enrollment
- 115 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
vulva; candidiasis